The medicine sector in India presents a challenging landscape, increasingly marked by concerns surrounding dominance . While the nation boasts a vibrant generic sector , a few large companies exert a substantial share of the business , prompting questions about fair practice and patient access to affordable treatments. This situation is fueled by a

The pharmaceutical landscape in the nation is increasingly characterized by a appearance toward market dominance, with a handful of major companies wielding significant influence. These business giants, often bolstered by long-standing distribution networks and robust brand recognition, present a difficult picture for competition and accessible hea

The Indian pharmaceutical industry, known for its affordable and accessible medicines, faces increasing concerns about monopolies. A few dominant companies control a significant percentage of the market, potentially limiting competition and driving up prices for consumers. This situation raises worries about the long-term impact on patient access